{{Rsnum
|rsid=9400317
|Gene=AKD1
|Chromosome=6
|position=109686444
|Orientation=plus
|GMAF=0.05923
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=AK9
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.9 | 23.9 | 75.2
| HCB | 0.0 | 1.5 | 98.5
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 1.8 | 98.2
| CHB | 0.0 | 1.5 | 98.5
| CHD | 0.0 | 0.0 | 0.0
| GIH | 2.0 | 29.7 | 68.3
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 10.3 | 89.7
| MKK | 0.6 | 9.6 | 89.7
| TSI | 0.0 | 31.4 | 68.6
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=19684573
|Trait=Response to Hepatitis C treatment
|Title=Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
|RiskAllele=
|Pval=0.000007
|OR=NR
|ORtxt=NR
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs9400317
|overall_frequency_n=119
|overall_frequency_d=128
|overall_frequency=0.929688
|n_genomes=55
|n_genomes_annotated=0
|n_haplomes=106
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}